DOCSLIB.ORG

OMNIC Standard

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
OMNIC Standard OMNIC Standard Spectral Library Listing OMNIC Standard includes 1,421 spectra of general chemical compounds. Six sample libraries which are subsets of full libraries are included along with the 842 compound Nicolet Condensed Phase Sampler* containing a wide selection of common materials. The following libraries are included: ¾ Aldrich Condensed Phase Sample Library (101) ¾ Aldrich Vapor Phase Sample Library (112) ¾ Georgia State Crime Lab Sample Library (200) ¾ Hummel Polymer Sample Library (53) ¾ Organics by Raman Sample Library (21) ¾ Sigma Biological Sample Library (92) ¾ Nicolet Condensed Phase Sampler (842)* * Not included with OMNIC Lite Aldrich Condensed Phase Sample Library Index Compound Name Index Compound Name 34 (+)-2,2,2-TRIFLUORO-1-(9- 55 BENZOIC ANHYDRIDE, 98% ANTHRYL)ETHANOL, 98+% 61 BENZONITRILE, 99+%, 7 (+)-BETA-D-LACTOSE SPECTROPHOTOMETRIC GRADE, 16 (+/-)-BETA-BUTYROLACTONE, GOLD LABEL 98+% 56 BENZOYL CHLORIDE, 99+%, GOLD 4 1,3-DICHLOROBUTANE, 99% LABEL 21 1,6-DICYANOHEXANE, 99% 62 BENZYL ISOTHIOCYANATE, 98% 5 1,6-HEPTADIEN-4-OL, 97% 66 BENZYL SULFOXIDE, 98% 25 1-DODECANESULFONIC ACID 94 BORANE-TRIMETHYLAMINE SODIUM SALT, 99+% COMPLEX 24 1-HEPTANESULFONIC ACID, 19 BUTYRAMIDE SODIUM SALT, 98% 99 CARBONYLBIS 2 1-HEXENE, 99% (TRIPHENYLPHOSPHINE) 87 1-PENTYNE, 99+% IRIDIUM(I) CHLORIDE, 42 1-PHENYL-1,2- PROPANEDIONE, 99.99%,GOLD LABE 99% 8 CHLOROMETHYL ETHYL ETHER, 47 2-BROMOBENZALDEHYDE, 99% 96% 46 2-CHLOROBENZALDEHYDE, 97% 90 CHOLESTEROL, 98% 22 2-CHLOROETHYL ISOCYANATE, 54 COUMARIN 95% 86 CYCLOHEXANONE OXIME, 97% 52 2-COUMARANONE, 97% 6 D-(-)-FRUCTOSE, 98% 3 2-IODOPROPANE, 97% 26 DIBUTYL PHOSPHITE, 96% 10 3-NONANONE, 99% 15 DIETHYL ETHYLMALONATE, 99% 100 3C2\LANTHANUM SULFATE 53 DIHYDROCOUMARIN, 99% NONAHYDRATE, 99.999%, GOLD 78 DIPHENYL PHOSPHITE LABEL 75 DIPHENYLPHOSPHINE 43 4,4PR-DICHLOROBENZOPHENONE, 80 DIPHENYLPHOSPHINIC ACID, 99% 99% 23 ETHANESULFONIC ACID 79 5-AMINO-2- 51 ETHYL BENZOATE, 99+% METHYLBENZOTHIAZOLE 14 ETHYL ISOBUTYRATE, 99% DIHYDROCHLORIDE 89 FAST GARNET GBC BASE, 97% 85 ACETALDOXIME, 95% 57 FORMANILIDE, 97% 58 ACETANILIDE, 97% 9 ISOBUTYLAMINE, 99% 41 ACETOPHENONE, 99% 20 ISOBUTYRONITRILE, 99% 98 ACRYLONITRILE/ BUTADIENE 88 LITHIUM ACETYLIDE, COPOLYMER, ACRYLONITRILE ETHYLENEDIAMINE COMPLEX, CONTENT 19-22% 90% 37 ANILINE HYDROCHLORIDE, 97% 76 METHYL DIPHENYLPHOSPHINE, 36 ANILINE, 99.5+%, GOLD LABEL, 99% A.C.S. REAGENT 64 N,N'-DI-P-TOLYLCARBODIIMIDE, 32 ANISOLE, 99% 97% 30 ANTHRACENE, 99.9%, GOLD 38 N,N-DIMETHYLANILINE, 99% LABEL 60 N-METHYLBENZAMIDE, 99+% 44 BENZALDEHYDE, 98+% 73 N-THIONYLANILINE, 98% 59 BENZAMIDE, 99% 40 NITROBENZENE, 99+%, A.C.S. 28 BENZENE, 99+%, REAGENT, GOLD LABEL SPECTROPHOTOMETRIC GRADE, 39 NITROSOBENZENE, 97% GOLD LABEL 12 NONANOIC ACID, 98% 68 BENZENESULFINIC ACID, SODIUM 11 NONYL ALDEHYDE, 98% SALT, 97% 97 NYLON 6/10 74 BENZENESULFONAMIDE, 98+% 91 OCTANE-D18,98+ ATOM % D 69 BENZENESULFONIC ACID, TECH., 45 ORTHO-FLUOROBENZALDEHYDE, 90% 97% 70 BENZENESULFONYL CHLORIDE, 72 P-TOLUENESULFONYL CHLORIDE, 99% 99+%, GOLD LABEL 48 BENZOIC ACID, 99+%, GOLD 31 PARA-CHLOROBIPHENYL, 99% LABEL, A.C.S. REAGENT 80 DIPHENYLPHOSPHINIC ACID, 99% 50 BENZOIC ACID, SODIUM SALT, 23 ETHANESULFONIC ACID 99+% 51 ETHYL BENZOATE, 99+% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 1 of 2 Aldrich Condensed Phase Sample Library Index Compound Name Index Compound Name 14 ETHYL ISOBUTYRATE, 99% 17 PENTAFLUOROPROPIONIC 89 FAST GARNET GBC BASE, 97% ANHYDRIDE, 99% 57 FORMANILIDE, 97% 33 PHENOL, 99+% 9 ISOBUTYLAMINE, 99% 63 PHENYL ISOCYANATE, 98+% 20 ISOBUTYRONITRILE, 99% 82 PHENYL PHOSPHATE, DISODIUM 88 LITHIUM ACETYLIDE, SALT DIHYDRATE, 98% ETHYLENEDIAMINE COMPLEX, 67 PHENYL SULFONE, 97% 90% 65 PHENYL SULFOXIDE, 97% 76 METHYL DIPHENYLPHOSPHINE, 81 PHENYLPHOSPHONIC ACID, 98% 99% 96 POLY(ETHYLENE GLYCOL), 64 N,N'-DI-P-TOLYLCARBODIIMIDE, AVERAGE M.W. 1,000 97% 95 POLY(ETHYLENE), LOW DENSITY 38 N,N-DIMETHYLANILINE, 99% 13 PROPIONIC ACID, SODIUM SALT, 60 N-METHYLBENZAMIDE, 99+% 99% 73 N-THIONYLANILINE, 98% 84 PYRIDINE, 40 NITROBENZENE, 99+%, A.C.S. SPECTROPHOTOMETRIC GRADE, REAGENT, GOLD LABEL 99+%, GOLD LABEL (MEETS ACS 39 NITROSOBENZENE, 97% REQ.) 12 NONANOIC ACID, 98% 83 PYRROLE, 98% 11 NONYL ALDEHYDE, 98% 93 SILICONE OIL, FOR MP & BP 97 NYLON 6/10 APPARATUS 91 OCTANE-D18,98+ ATOM % D 101 SODIUM THIOSULFATE, 45 ORTHO-FLUOROBENZALDEHYDE, ANHYDROUS 97% 49 THIOBENZOIC ACID, TECH., 90% 72 P-TOLUENESULFONYL CHLORIDE, 35 THIOPHENOL, 99+%, GOLD LABEL 99+%, GOLD LABEL 29 TOLUENE, 99+%, 31 PARA-CHLOROBIPHENYL, 99% SPECTROPHOTOMETRIC GRADE, 71 PARA-TOLUENESULFONYL GOLD LABEL FLUORIDE, 97% 1 TRIACONTANE, 99% 17 PENTAFLUOROPROPIONIC 27 TRIETHYL PHOSPHATE, 99% ANHYDRIDE, 99% 77 TRIPHENYLPHOSPHINE, 99% 33 PHENOL, 99+% 18 VALERYL CHLORIDE, 98% 71 PARA-TOLUENESULFONYL 92 000METHYLTRIMETHOX FLUORIDE, 97% YSILANE, 99% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 2 of 2 Aldrich Vapor Phase Sample Library Index Compound Name Index Compound Name 102 (+)-DIHYDROCARVONE, 98%, 92 4-ETHYLBENZYL ALCOHOL, 99% MIXTURE OF ISOMERS 93 4-NITRO-M-XYLENE, 98% 86 (+/-)-CAMPHOR, 97% 89 4-PROPYLPHENOL, 99% 106 (+/-)-MENTHYL ACETATE, 97%, 30 4-VINYL-1-CYCLOHEXENE, 99% MIXTURE OF CIS AND TRANS 66 ALPHA-ANGELICALACTONE, 98% 52 (-)-CAMPHENE, 95% 87 ALPHA-BROMO-P-XYLENE, 98% 50 (1R)-(+)-ALPHA-PINENE, 98% 57 ALPHA-TERPINEOL, 98% 100 (1R)-(+)-CAMPHOR 98 BENZYL ACETATE, 99+% 84 (1R)-(-)-FENCHONE, 98+% 73 BENZYL ALCOHOL, 99% 56 (1R,2S,5R)-(-)-MENTHOL 112 CARBON DISULFIDE, 99+%, 40 (1S)-(-)-BETA-PINENE, 98% SPECTROPHOTOMETRIC GRADE 83 (1S)-(-)-VERBENONE, 94% 27 CHLOROFORM, 99+%, 51 (R)-(+)-LIMONENE, 97% SPECTROPHOTOMETRIC GRADE 55 (R,R)-(+)-P-MENTH-1-EN-9-OL, 97% 2 CYCLOHEPTANE, 98% 97 1,2,3,4- 25 CYCLOHEXYL MERCAPTAN TETRAHYDRONAPHTHALENE- 103 CYCLOOCTANONE, 98% D12, 99 ATOM % D 65 CYCLOPENTANE, 13 1,3-BUTANEDIOL SPECTROPHOTOMETRIC GRADE 15 1,4-BUTANEDIOL 16 DECANE, 99+%, GOLD LABEL 46 1,4-CYCLOHEXADIENE, 97% 109 DICHLOROMETHANE, 99+%, 10 1,4-DIMETHYLCYCLOHEXANE, SPECTROPHOTOMETRIC GRADE 99%, MIXTURE OF CIS AND 28 DICYCLOPENTADIENE, 95% TRANS 53 DIIODOMETHANE, 99% 71 1,4-DIOXANE, 99+% 24 DIMETHYL SUCCINATE, 99% 54 1,6-HEPTADIEN-4-OL, 97% 94 EPSILON-CAPROLACTAM, 99% 39 1-BROMOADAMANTANE, 99% 41 ETHER, A.C.S. REAGENT, 9 1-ETHYLPIPERIDINE, 99% ABSOLUTE 68 1-METHYLPIPERAZINE, 98% 17 ETHYL ACETATE, 99.5+%, 1 1-OCTANOL, 99+%, GOLD LABEL SPECTROPHOTOMETRIC GRADE 32 1-PENTEN-3-OL, 99% 37 ETHYL CAPRYLATE, 99+% 85 1-PHENYLHEXANE, 97% 81 FLUOROBENZENE-D5, 98+ 111 2,2,4-TRIMETHYLPENTANE, 99%, ATOM % D SPECTROPHOTO-METRIC GRADE 74 HEPTANE, 99% 38 2,3-BUTANEDIOL 44 HEXYLAMINE, 99% 5 2,3-DIBROMOPROPANOL, 96% 91 INDOLINE, 99% 36 2,3-DICHLOROANISOLE, 99% 64 ISOBUTYLAMINE, 99% 88 2,3-DIMETHOXYPHENOL, 98% 104 ISOPHORONE, 97% 75 2,4,6-COLLIDINE, 99+% 8 METHACRYLIC ACID, BUTYL 33 2,4,6-TRICHLOROPHENOL, 98% ESTER 23 2,4-DIMETHYL-3-PENTANOL, 99% 21 METHACRYLIC ACID, ISOBUTYL 80 2,5-DIMETHYLPYRROLE, 99+% ESTER 11 2,6,10,14- 76 METHOXYACETYL CHLORIDE, TETRAMETHYLPENTADECANE, 99% 96% 14 METHYL ALCOHOL, 99.9%, 99 2-BENZYLPYRIDINE, 98% SPECTROPHOTOMETRIC GRADE 60 2-FLUOROETHANOL, 95% 3 METHYLCYCLOHEXANE, 99% 20 2-METHOXYETHANOL, 99%, 18 N,N-DIMETHYLANILINE, 99% SPECTROPHOTOMETRIC GRADE 63 N-ETHYLURETHANE, 99% 6 2-METHYL-1-PENTANOL, 95% 35 NAPHTHALENE 77 2-METHYLPYRAZINE, 99+% 101 NORCAMPHOR, 97% 19 2-PROPANOL, 99+% 34 O-NITRO-PHENOL 79 2-PYRIDINECARBOXALDEHYDE, 47 ORTHO-VANILLIN, 99% 99% 12 P-TOLUALDEHYDE, 97% 108 2-PYRROLIDINONE, 98% 110 PELARGONALDEHYDE 61 3,4-DIHYDRO-2H-PYRAN, 97% 43 PERHYDROFLUORENE 90 3,5-DIMETHYLPHENOL, 99+% 82 PHENOL-D6, 98+ ATOM % D 78 3-ETHYLTOLUENE, 99% 70 PHORONE, TECH., 93% 62 3-NONANONE, 99% 22 PINACOLONE, 95% 69 4-AMINOMORPHOLINE, 99% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 1 of 2 Aldrich Vapor Phase Sample Library Index Compound Name Index Compound Name 59 PROPYL ETHER, 99+%, GOLD 7 TRANS-2-HEXENE, 99+%, GOLD LABEL LABEL 96 PYRAZOLE, 98% 31 TRANS-4-OCTENE, 99% 72 PYRIDAZINE, 97% 49 TRANS-PIPERYLENE, 98% 67 PYRROLIDINE, 99% 26 TRICHLOROACETONITRILE, 98% 95 QUINOLINE, 98% 48 TRIDECANE, 99+% 58 TERPINEN-4-OL, 95% 105 TROPINONE, 97% 4 TERT-BUTYLBENZENE, 99% 45 UNDECANE, 99% 29 TETRAHYDROPYRAN, 99% 107 VALERALDEHYDE, 99% 42 THIAZOLIDINE, 97% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 2 of 2 Georgia State Crime Lab Sample Library Index Compound Name Index Compound Name 195 (1- 111 CHLORDIAZEPOXIDE HCL IN KBR PHENYLCYCLOHEXYL)ETHYLAMI 110 CHLORDIAZEPOXIDE IN KBR NE 93 CHLORO-METHAQUALONE IN 106 (1- KBR PHENYLCYCLOHEXYL)ETHYLAMI 187 CHLOROQUINE IN KBR NE 174 CHLOROQUINE PO4 IN KBR 10 1(1,2- 186 CHLORPHENIRAMINE IN KBR THIENYL)CYCLOHEXYLPIPERIDIN 185 CHLORPHENIRAMINE MALEATE 9 1-(1-(2- IN KBR THIENYL)CYCLOHEXYL)MORPHO 72 CHLORPROMAZINE IN KBR 27 2,4,5-TRIMETHOXYAMPHETAMINE 191 CHLORZOXAZONE IN KBR 28 2,4,6-TRIMETHOXYAMPHETAMINE 172 CINCHOCAINE HCL IN KBR 76 2,4-DIMETHOXYAMPHETAMINE 32 CLONAZEPAM IN KBR HCL IN K 61 CLORAZEPATE DIPOTASSIUM IN 45 2,5-DIMETHOXY-4- KBR ETHYLAMPHETAMINE 151 CLORTERMINE HCL IN KBR 49 2,5-DIMETHOXY-4- 1 COCAINE HCL IN KBR METHYLAMPHETAMINE 178 COCAINE IN KBR 29 2,5-DIMETHOXYAMPHETAMINE 24 CODEINE IN KBR HCL 62 CODEINE PHOSPHATE IN KBR 42 2-METHOXY-4,5-MDA HCL IN KBR 13 D-2-BROMO-LSD IN KBR 44 3,4,5-TRIMETHOXYAMPHETAMINE 48 D-PSEUDOEPHEDRINE HCL IN KBR 46 3,4- 52 DELTA-8- METHYLENEDIOXYAMPHETAMIN TETRAHYDROCANNABINOL E HCL 50 DELTA-9- 102 4-BROMO-2,5- TETRAHYDROCANNABINOL DIMETHOXYAMPHETAMINE 199 DEXBROMPHENIRAMINE 41 4-METHOXYAMPHETAMINE IN MALEATE IN KBR KBR 30 DEXTROMETHORPHAN IN KBR 190 5-METHOXY-N,N- 121 DEXTROSE ANHYDROUS POWDER
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
    US 2004O224012A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn et al. (43) Pub. Date: Nov. 11, 2004 (54) TOPICAL APPLICATION AND METHODS Related U.S. Application Data FOR ADMINISTRATION OF ACTIVE AGENTS USING LIPOSOME MACRO-BEADS (63) Continuation-in-part of application No. 10/264,205, filed on Oct. 3, 2002. (76) Inventors: Pichit Suvanprakorn, Bangkok (TH); (60) Provisional application No. 60/327,643, filed on Oct. Tanusin Ploysangam, Bangkok (TH); 5, 2001. Lerson Tanasugarn, Bangkok (TH); Suwalee Chandrkrachang, Bangkok Publication Classification (TH); Nardo Zaias, Miami Beach, FL (US) (51) Int. CI.7. A61K 9/127; A61K 9/14 (52) U.S. Cl. ............................................ 424/450; 424/489 Correspondence Address: (57) ABSTRACT Eric G. Masamori 6520 Ridgewood Drive A topical application and methods for administration of Castro Valley, CA 94.552 (US) active agents encapsulated within non-permeable macro beads to enable a wider range of delivery vehicles, to provide longer product shelf-life, to allow multiple active (21) Appl. No.: 10/864,149 agents within the composition, to allow the controlled use of the active agents, to provide protected and designable release features and to provide visual inspection for damage (22) Filed: Jun. 9, 2004 and inconsistency. US 2004/0224012 A1 Nov. 11, 2004 TOPCAL APPLICATION AND METHODS FOR 0006 Various limitations on the shelf-life and use of ADMINISTRATION OF ACTIVE AGENTS USING liposome compounds exist due to the relatively fragile LPOSOME MACRO-BEADS nature of liposomes. Major problems encountered during liposome drug Storage in vesicular Suspension are the chemi CROSS REFERENCE TO OTHER cal alterations of the lipoSome compounds, Such as phos APPLICATIONS pholipids, cholesterols, ceramides, leading to potentially toxic degradation of the products, leakage of the drug from 0001) This application claims the benefit of U.S.
    [Show full text]
  • Texas Controlled Substances Act
    HEALTH AND SAFETY CODE TITLE 6. FOOD, DRUGS, ALCOHOL, AND HAZARDOUS SUBSTANCES SUBTITLE C. SUBSTANCE ABUSE REGULATION AND CRIMES CHAPTER 481. TEXAS CONTROLLED SUBSTANCES ACT SUBCHAPTER A. GENERAL PROVISIONS Sec.A481.001.AASHORT TITLE. This chapter may be cited as the Texas Controlled Substances Act. Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. Sept. 1, 1989. Sec.A481.002.AADEFINITIONS. In this chapter: (1)AA"Administer" means to directly apply a controlled substance by injection, inhalation, ingestion, or other means to the body of a patient or research subject by: (A)AAa practitioner or an agent of the practitioner in the presence of the practitioner; or (B)AAthe patient or research subject at the direction and in the presence of a practitioner. (2)AA"Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. The term does not include a common or contract carrier, public warehouseman, or employee of a carrier or warehouseman acting in the usual and lawful course of employment. (3)AA"Commissioner" means the commissioner of state health services or the commissioner 's designee. (4)AA"Controlled premises" means: (A)AAa place where original or other records or documents required under this chapter are kept or are required to be kept; or (B)AAa place, including a factory, warehouse, other establishment, or conveyance, where a person registered under this chapter may lawfully hold, manufacture, distribute, dispense, administer, possess, or otherwise dispose of a controlled substance or other item governed by the federal Controlled Substances Act (21 U.S.C.
    [Show full text]
  • DRUGS and DRIVING: January 1978 a SELECTED BIBLIOGRAPHY 6
    Technical Report Pocumtotim Pago 1. Rmrr He I. krrmmt Acce#r~mMe. (<izi19 ----- -- J. Ropott Oete DRUGS AND DRIVING: January 1978 A SELECTED BIBLIOGRAPHY 6. Pr~orn~ng~~gan~gotion code ----- . 8. Pmrfomrng Organctat~onUrnport NO. Alan C. Donelson UM-HSRI-78-3 10 Woh Un~tNo (TRAIS) I I. Conttect or Grant No. DOT-HS-7-01530 13. Type of Repoft and Petlod Covmrd ---------- '1 dministration , July 1975 - November 1976 14. Sponsoring Agency Codr This report presents a first supplement to Drugs and Driving: A Selected Bibliography (HS - 802 188), a bibliography of literature dealing with the relationship between drug use (other than alcohol alone) and highway safety. This supplement both updates the parent volume and expands coverage in certafn research areas related to the field of drugs and highway safety. In particular, 1i terature pertaining to drug usage patterns and drug analytical methodology has been included. A detailed description of the 1i terature scope and document selection process is provided. I I The bi bliography consists of four appendices, including a Topical Index, an Author Index, a Title Index, and Abstracts of nearly 400 i articles. A revised topical index was developed to improve user access to document abstracts. Within the topical index are cross-referenced lists of drugs by name and by usage. - ----&* 17. KO? Words 18. Dimhhtion Stotrmmnt Drugs, Drug Impaired Driving, Drug Avai labil ity is unlimited. Document Effect\, Drug Analytical Method01 ogy, may be re1eased to PIational Technical Drug Concentration-Effect Relation- 1 Information Service, Springfield, VA ships, Countermeasures 22161 for sale to public.
    [Show full text]
  • Georgia State Crime Lab Sample Library Georgia State Forensic Drugs
    Georgia State Crime Lab Sample Library Library Listing – 200 spectra This library contains a sampling of spectra from the Georgia State Forensic Drug library. It is only available as an example library with OMNIC spectroscopy software. The description for the complete Georgia State library is shown below. Georgia State Forensic Drugs Library Listing – 1,940 spectra This definitive forensic library is one of the most extensively used collections for the identification of drug substances. The Georgia State Crime Lab Drug Library contains FT-IR spectra of illegal and legal drugs as well as diluents, precursors and other drug-related compounds. The library consists of spectra that were acquired by the Georgia Bureau of Investigation. The samples were secured as pure drug standards from the U.S. Drug Enforcement Administration (DEA), Applied Science Laboratories, U.S. Pharmacopoeial Conventions, Inc., and various pharmaceutical companies. For the majority of samples the material purity is 95% or better and in many cases is greater than 99%. Unless otherwise stated, the samples were prepared for spectral analysis using KBr pellets. Georgia State Crime Lab Sample Library Index Compound Name Index Compound Name 195 (1- 110 CHLORDIAZEPOXIDE IN KBR PHENYLCYCLOHEXYL)ETHYLAMI 93 CHLORO-METHAQUALONE IN NE KBR 106 (1- 187 CHLOROQUINE IN KBR PHENYLCYCLOHEXYL)ETHYLAMI 174 CHLOROQUINE PO4 IN KBR NE 186 CHLORPHENIRAMINE IN KBR 10 1(1,2- 185 CHLORPHENIRAMINE MALEATE THIENYL)CYCLOHEXYLPIPERIDIN IN KBR 9 1-(1-(2- 72 CHLORPROMAZINE IN KBR THIENYL)CYCLOHEXYL)MORPHO
    [Show full text]
  • On the Approximation of the Laws of the Member States Relating to Cosmetic Products (76/768/EEC )
    27 . 9 . 76 Official Journal of the European Communities No L 262/169 COUNCIL DIRECTIVE of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC ) THE COUNCIL OF THE EUROPEAN COMMUNITIES, regards the composition, labelling and packaging of cosmetic products ; Having regard to the Treaty establishing the Euro­ pean Economic Community, and in particular Whereas this Directive relates only to cosmetic prod­ Article 100 thereof, ucts and not to pharmaceutical specialities and medicinal products ; whereas for this purpose it is necessary to define the scope of the Directive by Having regard to the proposal from the Commission, delimiting the field of cosmetics from that of phar­ maceuticals ; whereas this delimitation follows in particular from the detailed definition of cosmetic Having regard to the opinion of the European Parlia­ products, which refers both to their areas of appli­ ment ( 1 ), cation and to the purposes of their use; whereas this Directive is not applicable to the products that fall Having regard to the opinion of the Economic and under the definition of cosmetic product but are Social Committee (2 ), exclusively intended to protect from disease; whereas, moreover, it is advisable to specify that certain prod­ ucts come under this definition, whilst products Whereas the provisions laid down by law, regulation containing substances or preparations intended to be or administrative action in force in the Member ingested, inhaled, injected or implanted in the human States
    [Show full text]
  • CREW NPS Booklet
    NEW Psychoactive DRUGS V1.7 05/15 Service availability Drop-in: Monday – Wednesday: 1pm – 5pm, Thursday: 3pm – 7pm, Friday – Saturday: 1pm – 5pm, Sunday: Closed Telephone information and support: Monday – Friday: 10am – 5pm Online information and chatroom support: www.mycrew.org.uk Address | 32 Cockburn Street | Edinburgh | EH1 1PB Telephone | 0131 220 3404 Email | [email protected] Main | www.crew2000.org.uk Enterprise | www.mindaltering.co.uk Info and support | www.mycrew.org.uk Facebook | www.facebook.com/Crew2000 Twitter | www.twitter.com/Crew_2000 Instagram | www.instagram.com/Crew_2000 This booklet has been designed to expand worker knowledge and confidence in the area of NPS. It is most useful when discussed as part of Crew’s NPS training. Crew was established in 1992, in response to the rapid expansion of recreational drug use. We provide up-to-date information on the drugs that people are taking so they can make informed decisions about their own health. This is achieved using a stepped care approach and through collaboration with volunteers, service users and professionals. Crew neither condemns nor condones drug use, but we believe there are ways to reduce harm to health. As a national agency, Crew is at the forefront of emerging drug trends and we engage at all levels including service development, practice and policy. Our services include: – Support line: non-judgmental drug and sexual health information and support. – Drop-in: drug and sexual health information, condoms (NHS c:card service) and DJ workshops. – Outreach services: we provide welfare at large events, such as clubs and festivals to educate revellers on partying safely.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Appendix-2Final.Pdf 663.7 KB
    North West ‘Through the Gate Substance Misuse Services’ Drug Testing Project Appendix 2 – Analytical methodologies Overview Urine samples were analysed using three methodologies. The first methodology (General Screen) was designed to cover a wide range of analytes (drugs) and was used for all analytes other than the synthetic cannabinoid receptor agonists (SCRAs). The analyte coverage included a broad range of commonly prescribed drugs including over the counter medications, commonly misused drugs and metabolites of many of the compounds too. This approach provided a very powerful drug screening tool to investigate drug use/misuse before and whilst in prison. The second methodology (SCRA Screen) was specifically designed for SCRAs and targets only those compounds. This was a very sensitive methodology with a method capability of sub 100pg/ml for over 600 SCRAs and their metabolites. Both methodologies utilised full scan high resolution accurate mass LCMS technologies that allowed a non-targeted approach to data acquisition and the ability to retrospectively review data. The non-targeted approach to data acquisition effectively means that the analyte coverage of the data acquisition was unlimited. The only limiting factors were related to the chemical nature of the analyte being looked for. The analyte must extract in the sample preparation process; it must chromatograph and it must ionise under the conditions used by the mass spectrometer interface. The final limiting factor was presence in the data processing database. The subsequent study of negative MDT samples across the North West and London and the South East used a GCMS methodology for anabolic steroids in addition to the General and SCRA screens.
    [Show full text]
  • NIDA Drug Supply Program Catalog, 25Th Edition
    RESEARCH RESOURCES DRUG SUPPLY PROGRAM CATALOG 25TH EDITION MAY 2016 CHEMISTRY AND PHARMACEUTICS BRANCH DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES NATIONAL INSTITUTE ON DRUG ABUSE NATIONAL INSTITUTES OF HEALTH DEPARTMENT OF HEALTH AND HUMAN SERVICES 6001 EXECUTIVE BOULEVARD ROCKVILLE, MARYLAND 20852 160524 On the cover: CPK rendering of nalfurafine. TABLE OF CONTENTS A. Introduction ................................................................................................1 B. NIDA Drug Supply Program (DSP) Ordering Guidelines ..........................3 C. Drug Request Checklist .............................................................................8 D. Sample DEA Order Form 222 ....................................................................9 E. Supply & Analysis of Standard Solutions of Δ9-THC ..............................10 F. Alternate Sources for Peptides ...............................................................11 G. Instructions for Analytical Services .........................................................12 H. X-Ray Diffraction Analysis of Compounds .............................................13 I. Nicotine Research Cigarettes Drug Supply Program .............................16 J. Ordering Guidelines for Nicotine Research Cigarettes (NRCs)..............18 K. Ordering Guidelines for Marijuana and Marijuana Cigarettes ................21 L. Important Addresses, Telephone & Fax Numbers ..................................24 M. Available Drugs, Compounds, and Dosage Forms ..............................25
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • The Organic Chemistry of Drug Synthesis
    THE ORGANIC CHEMISTRY OF DRUG SYNTHESIS VOLUME 3 DANIEL LEDNICER Analytical Bio-Chemistry Laboratories, Inc. Columbia, Missouri LESTER A. MITSCHER The University of Kansas School of Pharmacy Department of Medicinal Chemistry Lawrence, Kansas A WILEY-INTERSCIENCE PUBLICATION JOHN WILEY AND SONS New York • Chlchester • Brisbane * Toronto • Singapore Copyright © 1984 by John Wiley & Sons, Inc. All rights reserved. Published simultaneously in Canada. Reproduction or translation of any part of this work beyond that permitted by Section 107 or 108 of the 1976 United States Copyright Act without the permission of the copyright owner is unlawful. Requests for permission or further information should be addressed to the Permissions Department, John Wiley & Sons, Inc. Library of Congress Cataloging In Publication Data: (Revised for volume 3) Lednicer, Daniel, 1929- The organic chemistry of drug synthesis. "A Wiley-lnterscience publication." Includes bibliographical references and index. 1. Chemistry, Pharmaceutical. 2. Drugs. 3. Chemistry, Organic—Synthesis. I. Mitscher, Lester A., joint author. II. Title. [DNLM 1. Chemistry, Organic. 2. Chemistry, Pharmaceutical. 3. Drugs—Chemical synthesis. QV 744 L473o 1977] RS403.L38 615M9 76-28387 ISBN 0-471-09250-9 (v. 3) Printed in the United States of America 10 907654321 With great pleasure we dedicate this book, too, to our wives, Beryle and Betty. The great tragedy of Science is the slaying of a beautiful hypothesis by an ugly fact. Thomas H. Huxley, "Biogenesis and Abiogenisis" Preface Ihe first volume in this series represented the launching of a trial balloon on the part of the authors. In the first place, wo were not entirely convinced that contemporary medicinal (hemistry could in fact be organized coherently on the basis of organic chemistry.
    [Show full text]
  • Toxicology Reference Material
    toxicology Toxicology covers a wide range of disciplines, including therapeutic drug monitoring, clinical toxicology, forensic toxicology (drug driving, criminal and coroners), drugs in sport and work place drug testing, as well as academia and research. Those working in the field have a professional interest in the detection and measurement of alcohol, drugs, poisons and their breakdown products in biological samples, together with the interpretation of these measurements. Abuse and misuse of drugs is one of the biggest problems facing our society today. Acute poisoning remains one of the commonest medical emergencies, accounting for 10-20% of hospital admissions for general medicine [Dargan & Jones, 2001]. Many offenders charged with violent crimes, or victims of violent crime may have been under the influence of drugs at the time the act was committed. The use of mind-altering drugs in the work place, or whilst in control of a motor vehicle places others in danger [Drummer, 2001]. Performance enhancing drugs in sport make for an uneven playing field and distract from the core ethic of sportsmanship. Patterns of drug abuse around the world are constantly evolving. They vary between geographies; from one country to another and even from region to region or population to population within countries. With a European presence, a wide reaching network of global customers and distributors, and activate participation in relevant professional societies, Chiron is well positioned to develop and deliver relevant, and current standards to meet customer demand in this challenging field. Chiron AS Stiklestadvn. 1 N-7041 Trondheim Norway Phone No.: +47 73 87 44 90 Fax No.: +47 73 87 44 99 E-mail: [email protected] Website: www.chiron.no Org.
    [Show full text]